Literature DB >> 1588409

Multiple vertebral hemangiomas with neurological signs. Case report.

M Djindjian1, J P Nguyen, A Gaston, J M Pavlovitch, J Poirier, I A Awad.   

Abstract

A case of multiple vertebral hemangiomas with progressive neurological deficit is presented. Successful treatment was accomplished using preoperative embolization, palliative surgical decompression, and postoperative radiation therapy. The patient has remained asymptomatic for 6 years. The authors review the role of current imaging modalities and options for therapeutic intervention. Preoperative embolization, palliative surgical decompression, and postoperative radiotherapy appear to provide a satisfactory outcome in patients with multiple hemangiomas and may represent an effective alternative to more aggressive surgical intervention.

Entities:  

Mesh:

Year:  1992        PMID: 1588409     DOI: 10.3171/jns.1992.76.6.1025

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Management of pediatric single-level vertebral hemangiomas presenting with myelopathy by three-pronged approach (ethanol embolization, laminectomy, and instrumentation): a single-institute experience.

Authors:  Pankaj Kumar Singh; P Sarat Chandra; Gaurang Vaghani; Dattaraj Paramanand Savarkar; Kanwaljeet Garg; Rajender Kumar; Shashant Sharad Kale; Bhawani Shankar Sharma
Journal:  Childs Nerv Syst       Date:  2015-12-21       Impact factor: 1.475

2.  Vertebral haemangiomas with spinal cord compression: the place of preoperative percutaneous vertebroplasty with methyl methacrylate.

Authors:  C Ide; A Gangi; A Rimmelin; R Beaujeux; D Maitrot; F Buchheit; F Sellal; J L Dietemann
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

3.  Outcome of dorsolumbar vertebral hemangiomas presenting with neuraxial compression.

Authors:  Anup P Nair; Raj Kumar; Arun Kumar Srivastav; Rabi Narayan Sahu; Brijesh Kumar
Journal:  Indian J Orthop       Date:  2012-09       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.